HORIZON-HLTH-2023-DISEASE-03
HORIZON-HLTH-2023-DISEASE-03
- Programme
- HORIZON
- Funded projects (dataset)
- 36
- EU contribution (sum)
- €229,274,352
- Portal deadline
- —
Leading topic in historical projects: HORIZON-HLTH-2023-DISEASE-03-07
Start here
Suggested partners for this call
Who coordinated consortia under this call, plus a complementary slice (topic leaders, research partners, or frequent non-coordinators). For industry lists, CSV export, and consortium size — open Proposal partner finder.
Top coordinators
Organisations that coordinated the most funded projects under this call.
- NORWEGIAN INSTITUTE OF PUBLIC HEALTH NIPH2 coordinated
- Fraunhofer2 coordinated
- UCPH2 coordinated
- UMC UTRECHT2 coordinated
- UNIVERSITAIR MEDISCH CENTRUM GRONINGEN1 coordinated
- Leiden University Medical Center1 coordinated
- BNI1 coordinated
- CHARITE - UNIVERSITAETSMEDIZIN BERLIN1 coordinated
- GERMAN CANCER RESEARCH CENTER1 coordinated
- DLR1 coordinated
- ERINHA1 coordinated
- FABENTECH1 coordinated
Organisations strong on this topic
Broader signal: frequent participants across funded projects tagged with the same topic codes as this call (not limited to coordinators).
- EUROPEAN ASSOCIATION FOR PALLIATIVE CARE7 topic projects
- ERASMUS MC4 topic projects
- KU Leuven4 topic projects
- CSIC3 topic projects
- CNRS3 topic projects
- REGIONH3 topic projects
- RADBOUDUMC3 topic projects
- UNIVERSITY OF TARTU3 topic projects
- UCP3 topic projects
Frequent collaborators
Pairs that often appear together in the same funded project under this call.
- 4 shared
- 3 shared
- 3 shared
- 2 shared
- RADBOUDUMC · FGF2 shared
NL ↔ PT
- RADBOUDUMC · UCPH2 shared
NL ↔ DK
- 2 shared
- 2 shared
- 2 shared
- 2 shared
- ERASMUS MC · ERINHA2 shared
NL ↔ BE
- 2 shared
- RADBOUDUMC · Lancaster University2 shared
NL ↔ UK
- RADBOUDUMC · UCP2 shared
NL ↔ PT
- UNIVERSITY OF TURKU · INSERM2 shared
FI ↔ FR
- ERASMUS MC · UVEG2 shared
NL ↔ ES
- ERASMUS MC · Kveloce I+D+i2 shared
NL ↔ ES
- 2 shared
Proposal partner finder
One page with suggested coordinators, strong and industry partners, topic leaders, typical consortium size, similar projects — plus CSV or print / PDF export for your shortlist.
Typical consortium pattern
Derived from historical funded projects linked to this CORDIS call in Grantibase.
- Avg. orgs / project
- 12.67
- Median orgs / project
- 12.5
- Min / max orgs
- 4 – 20
Country presence
Participant rows (an org can appear in multiple countries if data varies).
- Spain51
- France49
- Germany47
- Belgium36
- Netherlands35
- Italy32
- United Kingdom18
- Sweden18
- Switzerland15
- Portugal13
- Denmark13
- Czechia11
- Norway11
- Finland11
- United States9
- Hungary6
- Kenya5
- Austria5
Organization types
- university144 orgs · 195 rows
- research_institute105 orgs · 143 rows
- other29 orgs · 40 rows
- sme39 orgs · 40 rows
- public_body20 orgs · 23 rows
- company15 orgs · 15 rows
Topics in funded projects
- HORIZON-HLTH-2023-DISEASE-03-07HORIZON-HLTH-2023-DISEASE-03-07· 9 projects
- HORIZON-HLTH-2023-DISEASE-03-01HORIZON-HLTH-2023-DISEASE-03-01· 7 projects
- HORIZON-HLTH-2023-DISEASE-03-04HORIZON-HLTH-2023-DISEASE-03-04· 6 projects
- HORIZON-HLTH-2023-DISEASE-03-18HORIZON-HLTH-2023-DISEASE-03-18· 5 projects
- HORIZON-HLTH-2023-DISEASE-03-03HORIZON-HLTH-2023-DISEASE-03-03· 4 projects
- HORIZON-HLTH-2023-DISEASE-03-05HORIZON-HLTH-2023-DISEASE-03-05· 2 projects
- HORIZON-HLTH-2023-DISEASE-03-17HORIZON-HLTH-2023-DISEASE-03-17· 2 projects
- HORIZON-HLTH-2023-DISEASE-03-06HORIZON-HLTH-2023-DISEASE-03-06· 1 projects
Related funded projects
Largest EU contributions in this call — useful to see who already won funding on similar lines.
Open full project list in advanced search
| Project | Programme | EU contribution |
|---|---|---|
| SOLVE Sustainable COVID-19 Vaccination for Long-term Vaccine Immunity and Effectiveness | HORIZON | €8,972,900 |
| Yellow4FLAVI Deconstructing the protective immunity of yellow fever virus 17D to inform flavivirus vaccine design | HORIZON | €8,544,781 |
| FLAVIVACCINE Development and characterization of a pan-flavivirus vaccine candidate | HORIZON | €8,269,919 |
| EvaMobs Evolvable and rapidly adaptable monobodies: a broad-spectrum antiviral platform | HORIZON | €7,999,839 |
| PANVIPREP Developing broad-spectrum antiviral drugs for pandemic preparedness | HORIZON | €7,999,295 |
| VICI-DISEASE PROTECTION FROM VIRUSES WITH EPIDEMIC AND PANDEMIC DISEASE OUTBREAK POTENTIAL THROUGH DEVELOPMENT AND CLINICAL TESTING OF A NOVEL CAPSID VIRUS LIKE PARTICLE (CVLP) VACCINE | HORIZON | €7,952,496 |
| CCHFVACIM Crimean-Congo Haemorrhagic Fever Vaccine and Immunotherapy | HORIZON | €7,755,341 |
| e-FabRIC enhanced manufacturing of broadly potent equine polyclonal Fab with a Rational Immunization strategy against Coronaviruses | HORIZON | €7,666,549 |
| APPEAL Antivirus Pandemic Preparedness EuropeAn pLatform | HORIZON | €7,565,674 |
| BEHIND-MS The role of an Epstein-Barr virus infection in the pathogenesis of multiple sclerosis | HORIZON | €7,550,709 |
| EBV-MS Targeting Epstein-Barr Virus Infection for Treatment and Prevention of Multiple Sclerosis | HORIZON | €7,549,863 |
| AVITHRAPID Antiviral Therapeutics for Rapid Response Against Pandemic Infectious Diseases | HORIZON | €7,459,254 |
| MARVAX Development of novel viral vectored vaccines against Marburgviruses inducing robust and cross-reactive protection | HORIZON | €7,439,560 |
| COMMUTE COMORBIDITY MECHANISMS UTILIZED IN HEALTHCARE | HORIZON | €7,280,986 |
| ID-DarkMatter-NCD Unraveling the dark matter of infectious diseases, environmental and genetic factors tipping the balance towards NCDs | HORIZON | €7,185,361 |